T cell activation requires that the immunogen be presented in association with a major histocompatibility complex (MHC) class II molecule. Our long-term objective is to understand how antigen presentation in the context of self applies to alloimmune (transplantation) responses and, given the rich array to human class II molecules, which ones are used for which functions. We will use serologic, cellular, and molecular in approaches to pursue our objective. We will define epitopes of MHC molecules in structural terms using haplotypes with unusual linkage disequilibria and varient alleles that we have identified in different ethnic populations. The epitopes will be defined serologically, using allo- and monoclonal antibodies, and molecularly usng restriction endonucleases and genetic probes, to map and sequence gene segments. Epitopes of MHC molecules will also be investigated for their ability to serve as restriction elements for foreign antigen presentation to T lymphocytes. We will investigate the ability of certain mediators of gene expression to alter differentially the profile of MHC antigen expression and will analyze mechanisms involved in gene regulation of this expression. Lastly, we will investigate genetic basis for disease susceptibility in polyglandular failure disease, hodgkin's disease and type II diabetes using serologic and molecular probes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM010356-24
Application #
3268095
Study Section
Immunobiology Study Section (IMB)
Project Start
1974-10-01
Project End
1990-02-28
Budget Start
1987-03-01
Budget End
1988-02-28
Support Year
24
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Yi, Feng; DeCan, Evan; Stoll, Kurt et al. (2015) Muscarinic excitation of parvalbumin-positive interneurons contributes to the severity of pilocarpine-induced seizures. Epilepsia 56:297-309
Stierle, Andrea A; Stierle, Donald B; Girtsman, Teri et al. (2015) Azaphilones from an Acid Mine Extremophile Strain of a Pleurostomophora sp. J Nat Prod 78:2917-23
McClelland, Levi J; Mou, Tung-Chung; Jeakins-Cooley, Margaret E et al. (2014) Structure of a mitochondrial cytochrome c conformer competent for peroxidase activity. Proc Natl Acad Sci U S A 111:6648-53
Hall, R P; Ward, F E; Wenstrup, R J (1990) An HLA class II region restriction fragment length polymorphism (RFLP) in patients with dermatitis herpetiformis: association with HLA-DP phenotype. J Invest Dermatol 95:172-7
Hall, R P; Clark, R E; Ward, F E (1990) Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics. J Am Acad Dermatol 22:436-9
Brissette-Storkus, C S; Kostyu, D D; Boyer, C M et al. (1990) Induction of HLA-specific CTL to nonimmunogenic, heat-inactivated lymphocytes by interleukin 2. Transplantation 50:862-9
Markert, M L; Norby-Slycord, C; Ward, F E (1989) A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution. Am J Hum Genet 45:354-61
Ward, F E; Stewart, A D; Ruiz, R E et al. (1989) Epitopes within the HLA-B5,B35 cross-reacting group. Hum Immunol 26:151-67
Ward, F E; Jensen, J B; Abdul Hadi, N H et al. (1989) HLA genotypes and variant alleles in Sudanese families of Arab-Negroid tribal origin. Hum Immunol 24:239-51
Carrington, M N; Tharp-Hiltbold, B; Knoth, J et al. (1988) 1,25-Dihydroxyvitamin D3 decreases expression of HLA class II molecules in a melanoma cell line. J Immunol 140:4013-8

Showing the most recent 10 out of 24 publications